Conference Programming

The 2nd Africa HepatoPancreatoBiliary Cancers Consortium (AHPBCC) Annual Conference will convene a global, multi-disciplinary audience of the scientific, medical, and academic communities; industry partners, advocates and patients who represent a diversity of perspectives.

The Conference programming has been designed to harness resources and expertise across the African Continent, Europe, and the United States to inform strategies for improved survival of patients with cancers of the liver, biliary tract, and pancreas by:

  • Increasing the knowledge and understanding of attendees about key issues central to the prevention, diagnosis, treatment, and cure for HPB cancers in Africa
  • Identifying gaps and gathering consensus on rapidly changing advances in research
  • Stimulating international, multi-disciplinary, cross-cooperation and sharing of best practices
  • Fostering dialogue and inspiring innovation

Pre-conference Workshops on a variety of topics will have a diverse team of facilitators and presenters from within Africa, Europe, and the United States to provide multi-disciplinary, multi-cultural perspectives.

There will be cross-disciplinary oral and poster presentations focused on HPB cancers. Established investigators and clinicians, early career physicians and scientists, graduate students, and women in science from global institutions will be represented. Efforts have been made to ensure geographic and gender balance in the oral presentations. The Poster Session Planning Committee will select three poster presentations for recognition and certificate awards.

The Mentoring and Career Development Initiative will provide early career researchers with opportunities to develop and expand their education with guidance from a global community of renowned experts. Programming includes a half-day pre-conference workshop, with opportunities for oral abstracts, poster sessions, speaker presentations, and group discussions. A dedicated team of young investigators will forge new alliances, stimulate dialogue, and inspire innovation in the study of HepatoPancreatoBiliary Cancers, all with the common goal of improving the quality of life for those affected by these devastating cancers and ensuring that a pipeline of young investigators is recruited, cultivated, and encouraged to make this research their life’s work.

The AHPBCC 2022, 2023, and 2024 Conferences are supported in part by an R13 grant award from the United States National Cancer Institute.

Conference Agenda

Translate »
Scroll to Top